160 related articles for article (PubMed ID: 31182663)
1. Clinical and Technical Considerations for Brain PET Imaging for Dementia.
Acuff SN; Mathotaarachchi S; Zukotynski K; Osborne D; Subramaniam R;
J Nucl Med Technol; 2020 Mar; 48(1):5-8. PubMed ID: 31182663
[TBL] [Abstract][Full Text] [Related]
2. PET/CT of Dementia.
Zukotynski K; Kuo PH; Mikulis D; Rosa-Neto P; Strafella AP; Subramaniam RM; Black SE
AJR Am J Roentgenol; 2018 Aug; 211(2):246-259. PubMed ID: 29949415
[TBL] [Abstract][Full Text] [Related]
3. In vivo molecular imaging biomarkers: clinical pharmacology's new "PET"?
Nutt R; Vento LJ; Ridinger MH
Clin Pharmacol Ther; 2007 Jun; 81(6):792-5. PubMed ID: 17505491
[TBL] [Abstract][Full Text] [Related]
4. Positron emission tomography radiopharmaceuticals for imaging brain Beta-amyloid.
Vallabhajosula S
Semin Nucl Med; 2011 Jul; 41(4):283-99. PubMed ID: 21624562
[TBL] [Abstract][Full Text] [Related]
5. Brain FDG PET and the diagnosis of dementia.
Shivamurthy VK; Tahari AK; Marcus C; Subramaniam RM
AJR Am J Roentgenol; 2015 Jan; 204(1):W76-85. PubMed ID: 25539279
[TBL] [Abstract][Full Text] [Related]
6. A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives.
Morbelli S; Garibotto V; Van De Giessen E; Arbizu J; Chételat G; Drezgza A; Hesse S; Lammertsma AA; Law I; Pappata' S; Payoux P; Pagani M;
Eur J Nucl Med Mol Imaging; 2015 Sep; 42(10):1487-91. PubMed ID: 26067090
[No Abstract] [Full Text] [Related]
7. PET radiotracers for molecular imaging in dementia.
Baskin A; Giannakopoulos P; Ratib O; Seimbille Y; Assal F; Perani D; Garibotto V
Curr Radiopharm; 2013 Dec; 6(4):215-30. PubMed ID: 24283962
[TBL] [Abstract][Full Text] [Related]
8. [Amyloid positron-emission-tomography with [
Schönecker S; Prix C; Raiser T; Ackl N; Wlasich E; Stenglein-Krapf G; Mille E; Brendel M; Sabri O; Patt M; Barthel H; Bartenstein P; Levin J; Rominger A; Danek A
Nervenarzt; 2017 Feb; 88(2):156-161. PubMed ID: 27913818
[TBL] [Abstract][Full Text] [Related]
9. Guidelines for brain radionuclide imaging. Perfusion single photon computed tomography (SPECT) using Tc-99m radiopharmaceuticals and brain metabolism positron emission tomography (PET) using F-18 fluorodeoxyglucose. The Belgian Society for Nuclear Medicine.
Vander Borght T; Laloux P; Maes A; Salmon E; Goethals I; Goldman S;
Acta Neurol Belg; 2001 Dec; 101(4):196-209. PubMed ID: 11851026
[TBL] [Abstract][Full Text] [Related]
10. Role of positron emission tomography/computed tomography in dementia.
Hinds SR; Stocker DJ; Bradley YC
Radiol Clin North Am; 2013 Sep; 51(5):927-34. PubMed ID: 24010914
[TBL] [Abstract][Full Text] [Related]
11. Practice and prospects for PET/CT guided interventions.
Bogoni M; Cerci JJ; Cornelis FH; Nanni C; Tabacchi E; SchÖder H; Shyn PB; Sofocleous CT; Solomon SB; Kirov AS
Q J Nucl Med Mol Imaging; 2021 Mar; 65(1):20-31. PubMed ID: 33494585
[TBL] [Abstract][Full Text] [Related]
12.
Higashi T; Nishii R; Kagawa S; Kishibe Y; Takahashi M; Okina T; Suzuki N; Hasegawa H; Nagahama Y; Ishizu K; Oishi N; Kimura H; Watanabe H; Ono M; Saji H; Yamauchi H
Ann Nucl Med; 2018 Apr; 32(3):206-216. PubMed ID: 29388083
[TBL] [Abstract][Full Text] [Related]
13. Top-Down Systematic Approach to Interpretation of FDG-PET for Dementia.
Sawyer DM; Kuo PH
Clin Nucl Med; 2018 Jun; 43(6):e212-e214. PubMed ID: 29659399
[TBL] [Abstract][Full Text] [Related]
14. Autopsy as gold standard in FDG-PET studies in dementia.
Durand-Martel P; Tremblay D; Brodeur C; Paquet N
Can J Neurol Sci; 2010 May; 37(3):336-42. PubMed ID: 20481267
[TBL] [Abstract][Full Text] [Related]
15. [Technical Considerations on Scanning and Image Analysis for Amyloid PET in Dementia].
Akamatsu G; Ohnishi A; Aita K; Ikari Y; Yamamoto Y; Senda M
Nihon Hoshasen Gijutsu Gakkai Zasshi; 2017; 73(4):298-308. PubMed ID: 28428473
[TBL] [Abstract][Full Text] [Related]
16. Florbetapir F 18 for brain imaging of β-amyloid plaques.
Romano M; Buratti E
Drugs Today (Barc); 2013 Mar; 49(3):181-93. PubMed ID: 23527322
[TBL] [Abstract][Full Text] [Related]
17. Impact of (18)FDG PET and (11)C-PIB PET brain imaging on the diagnosis of Alzheimer's disease and other dementias in a regional memory clinic in Hong Kong.
Shea YF; Ha J; Lee SC; Chu LW
Hong Kong Med J; 2016 Aug; 22(4):327-33. PubMed ID: 27313272
[TBL] [Abstract][Full Text] [Related]
18. Flutemetamol (18F): a β-amyloid positron emission tomography tracer for Alzheimer's and dementia diagnosis.
de Lartigue J
Drugs Today (Barc); 2014 Mar; 50(3):219-29. PubMed ID: 24696867
[TBL] [Abstract][Full Text] [Related]
19. ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia.
Frey KA; Lodge MA; Meltzer CC; Peller PJ; Wong TZ; Hess CP; Petrella JR; Sair HI; Subramaniam RM
Clin Nucl Med; 2016 Feb; 41(2):118-25. PubMed ID: 26646994
[TBL] [Abstract][Full Text] [Related]
20. [Current and future prospects of nuclear medicine in dementia].
Ito K; Inui Y; Kizawa T; Kimura Y; Kato T
Rinsho Shinkeigaku; 2017 Sep; 57(9):479-484. PubMed ID: 28804110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
